BridgeMD
Tests treatment safety and results for Diabetic Retinopathy (DR)
Official title Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus
ClinicalTrials.gov ID: NCT07378956
What this study is testing
- What it's testing
- The objective of this study is to investigate the efficacy of implementing the AI-SaMD(VUNO Med®-Fundus AI™) alongside routine clinical practice for the detection of diabetic retinopathy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Adults aged 19 years or older.
- A documented diagnosis of type 2 diabetes mellitus.
- Ability to communicate adequately and provide written informed consent for participation in the study.
You likely can't join if
- A prior diagnosis of diabetic retinopathy at the time of screening.
- A history of ophthalmic surgery within 6 months prior to the screening date.
- A diagnosis of type 1 diabetes mellitus.
- Pregnancy at the time of screening.
- Any condition that, in the opinion of the investigator, would make participation in the study infeasible or inappropriate.
The study team makes the final eligibility decision.
Where it's taking place
- Incheon, Gyeonggi-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Incheon, Gyeonggi-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.